Very Early Nimodipine Use in Stroke "VENUS"

Terminated

Phase 3 Results

Summary of Purpose

To prospectively study the effects of nimodipine administered early after stroke onset.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 16 July 2008.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Dutch Prevention Fund. Medication supplied by Bayer AG.

Trial Design

Randomized. double-blind, placebo-controlled trial of 454 patients.

Contacts

  • M. Limburg, PO Box 22700, 1100 DE, Amsterdam, Netherlands.

    m.limburg@amc.uva.nl